The company is stock limited restructured from Staidson (Beijing) Pharmaceutical Co.,Ltd. In May, 2009, Staidson (Beijing) Pharmaceutical Co.,Ltd was restructured into a stock limited with net assets audited on April 30, 2009 by Lixin Yonghua. Lixin Yonghua verified its capital and issued its No. (2009) 0032 Capital Verification Report. On May 26, 2009, the company registered in Beijing Municipal Administration of Industry and Commerce and received Business License for Enterprise’s Legal Person with Registration No. 110302004270284.
Headquarters
No. 36, Jinghai 2nd Road, Beijing Economic and Technological Development Zone, Beijing
Beijing; Beijing;
Postal Code: 100176
Contact Details: Purchase the Staidson (Beijing) Biopharmaceuticals Co., Ltd. report to view the information.
Website: http://www.staidson.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service